Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

Abroad (travel likely)RecruitingPHASE4

Conditions

HIV · Substance Use Disorder (SUD) · Injection Drug Use

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Suzanne McCluskey, MD, MSc) · SMCCLUSKEY@MGH.HARVARD.EDU · 617-726-9488
Contact: Principal Investigator (Suzanne McCluskey, MD, MSc)
Fenway Health, Boston, Massachusetts, United States
Contact: Study coordinator (Julia Fleming, MD, MHS) · JFleming@fenwayhealth.org · 857-313-6984
Contact: Principal Investigator (Julia Fleming, MD, MHS)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MAPS PrEP Van Study

HIV Infection

Abroad (travel likely)RecruitingPHASE4

Durham, United States

Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals

HIV Infections

Abroad (travel likely)RecruitingPHASE4

Rio de Janeiro, Brazil

Viral Load in Blood and Lymph Tissues in People Living With HIV

HIV

Abroad (travel likely)Recruiting

Bethesda, United States

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants

HIV

Abroad (travel likely)Recruiting

Bethesda, United States